Published in Science on October 05, 2001
Under-representation of developing countries in the research literature: ethical issues arising from a survey of five leading medical journals. BMC Med Ethics (2004) 3.11
Research priorities. ELSI 2.0 for genomics and society. Science (2012) 2.10
Moral imagination: the missing component in global health. PLoS Med (2005) 1.56
Patenting of genetic material: are the benefits to society being realized? CMAJ (2002) 1.49
Neglected diseases: under-funded research and inadequate health interventions. Can we change this reality? EMBO Rep (2003) 1.29
How can developing countries harness biotechnology to improve health? BMC Public Health (2007) 1.06
Recommendations for genetic variation data capture in developing countries to ensure a comprehensive worldwide data collection. Hum Mutat (2011) 0.99
The impact of genomics on global health. Am J Public Health (2002) 0.97
"Harnessing genomics to improve health in Africa" - an executive course to support genomics policy. Health Res Policy Syst (2005) 0.92
Harnessing genomics to improve health in the Eastern Mediterranean Region - an executive course in genomics policy. Health Res Policy Syst (2005) 0.90
Neglected infectious diseases: are push and pull incentive mechanisms suitable for promoting drug development research? Health Econ Policy Law (2013) 0.90
Genetics and public health--evolution, or revolution? J Epidemiol Community Health (2004) 0.88
Consensus statement understanding health and malnutrition through a systems approach: the ENOUGH program for early life. Genes Nutr (2013) 0.88
Genetics in public health: Rarely explored. Indian J Hum Genet (2010) 0.87
Molecular genomic approaches to infectious diseases in resource-limited settings. PLoS Med (2009) 0.84
Biomedical research, a tool to address the health issues that affect African populations. Global Health (2013) 0.83
Trends in population-based studies of human genetics in infectious diseases. PLoS One (2012) 0.81
Human rights in the biotechnology era 1. BMC Int Health Hum Rights (2002) 0.81
A call for global governance of biobanks. Bull World Health Organ (2014) 0.80
Developing biobanks in developing countries. J Glob Health (2011) 0.78
Breast Cancer in Africa: Limitations and Opportunities for Application of Genomic Medicine. Int J Breast Cancer (2016) 0.76
Genomics and global health. BMJ (2002) 0.75
Connecting the Human Variome Project to nutrigenomics. Genes Nutr (2010) 0.75
The Governance of Genomic Information: Will it Come of Age? Genomics Soc Policy (2006) 0.75
Valorizing science: whose values? Science & society series on convergence research. EMBO Rep (2009) 0.75
Understanding biological mechanisms underlying adverse birth outcomes in developing countries: protocol for a prospective cohort (AMANHI bio-banking) study. J Glob Health (2017) 0.75
On parrots and thorns: Sri Lankan perspective on genetics, science and personhood. Health Care Anal (2007) 0.75
Biotech gap between North and South. Science (2001) 2.82
Public health. Grand Challenges in Global Health. Science (2003) 7.91
The case for allowing kidney sales. International Forum for Transplant Ethics. Lancet (1998) 5.25
The case for "presumed consent" in organ donation. International Forum for Transplant Ethics. Lancet (1998) 4.99
High mortality among recipients of bought living-unrelated donor kidneys. Lancet (1990) 4.25
Should organs from patients in permanent vegetative state be used for transplantation? International Forum for Transplant Ethics. Lancet (1997) 4.04
A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol (1992) 3.28
The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation (1984) 2.45
The detailed distribution of MHC Class II antigens in normal human organs. Transplantation (1984) 2.26
HLA antigens in Omanis with blinding trachoma: markers for disease susceptibility and resistance. Br J Ophthalmol (1997) 1.45
Anomolous expression of HLA-DR antigens on human colorectal cancer cells. J Immunol (1982) 1.44
Localization of major histocompatibility complex (HLA-ABC and DR) antigens in 46 kidneys. Differences in HLA-DR staining of tubules among kidneys. Transplantation (1983) 1.32
The membrane antigens of human colorectal cancer cells: demonstration with monoclonal antibodies of heterogeneity within and between tumours and of anomalous expression of HLA-DR. Eur J Cancer Clin Oncol (1983) 1.24
Chemical composition and tissue distribution of the human CDw44 glycoprotein. Immunology (1989) 1.23
Organ-specific IgM autoantibodies to liver, heart and brain in man: generalized occurrence and possible functional significance in normal individuals, and studies in patients with multiple sclerosis. Clin Exp Immunol (1981) 1.18
Analysis of the distribution of HLA-B alleles in populations from five continents. Hum Immunol (2001) 1.15
Analysis of the distribution of HLA-A alleles in populations from five continents. Hum Immunol (2000) 1.10
Chondroid syringoma of the nose: report of a case. J Laryngol Otol (1997) 1.02
Demonstration with monoclonal antibodies of an unusual mononuclear cell infiltrate and loss of normal epithelial membrane antigens in human breast carcinomas. Lancet (1981) 0.93
HLA antigens in Omani patients with vitiligo. Clin Exp Dermatol (1995) 0.90
Prostate cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men. Int Urol Nephrol (2006) 0.86
Paid organ donation--the grey basket concept. J Med Ethics (1998) 0.83
Marketing human organs: the autonomy paradox. Theor Med (1996) 0.82
Acute primary epiploic appendagitis. Br J Clin Pract (1981) 0.82
Cultural and psychological dimensions of human organ transplantation. Ann Transplant (1998) 0.82
Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus. Exp Clin Transplant (2005) 0.81
Schistosomiasis in patients in the Sultanate of Oman. Ann Saudi Med (2007) 0.81
The composition and properties of jacalin, a lectin of diverse applications obtained from the jackfruit (Artocarpus heterophyllus) seeds. Immunol Invest (1994) 0.80
Bidil: recontextualizing the race debate. Pharmacogenomics J (2008) 0.79
Prevalence of antibodies to hepatitis C virus among Omani patients with renal disease. Infection (1993) 0.79
Brachial plexus palsy and spinal subarachnoid pneumatosis following trauma. Clin Anat (1997) 0.79
Hepatitis B, delta and human immunodeficiency virus infections among Omani patients with renal diseases: A seroprevalence study. Ann Saudi Med (1994) 0.78
Rectal examination and acid phosphatase: evidence for persistence of a myth. Br Med J (Clin Res Ed) (1981) 0.78
Graft avulsion: an unreported complication of axillofemoral bypass grafts. Br J Surg (1978) 0.78
Letter: B-cell alloantibodies and renal allografts. Lancet (1976) 0.78
Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men. Prostate Cancer Prostatic Dis (2005) 0.77
Prevalence of hepatitis B, hepatitis delta, and human immunodeficiency virus infections in Omani patients with renal diseases. Transplant Proc (1992) 0.77
Brain death and organ transplantation: cultural bases of medical technology. Curr Anthropol (1994) 0.77
The binding of jacalin with rabbit immunoglobulin G. Immunol Invest (1995) 0.77
HLA antigens in an Omani population with dilated cardiomyopathy. Int J Cardiol (1996) 0.77
Applying genomics-related technologies for Africa's health needs. Afr J Med Med Sci (2007) 0.77
Development of morbid obesity after transplantation in Laurence Moon Biedle syndrome. Transplant Proc (2003) 0.77
The human Thy-1 molecule. Immunol Ser (1989) 0.76
Use of renal transplants from living donors. Practice is essential to alleviate shortage of organs. BMJ (1999) 0.75
Rectal examination and acid phosphatase. Br Med J (Clin Res Ed) (1981) 0.75
Characterization of HLA-B*3921 and confirmation of HLA-B*4415, two variant HLA-B alleles identified in the Omani population. Tissue Antigens (2000) 0.75
Unrelated living organ donation: ULTRA needs to go. J Med Ethics (2003) 0.75
Leucocytosis is not a manifestation of rejection. Br Med J (1977) 0.75
Laparoscopic surgery at Sultan Qaboos University Hospital. J Sci Res Med Sci (2000) 0.75
Xenotransplants: proceed with caution. Nature (1998) 0.75
Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs? Acta Chir Belg (2008) 0.75
Avoiding frankendrugs. Nat Biotechnol (2000) 0.75
Antibodies to hepatitis C virus in Omani patients with renal disease. Transplant Proc (1992) 0.75
Maturation of immunoglobulin-A binding proteins in the seeds of jackfruit. Biochem Mol Biol Int (1995) 0.75
Scrotal Cancer - a notifiable occupational disease. Br J Clin Pract (1982) 0.75
Schistosomiasis: clinical relevance to surgeons in Australasia and diagnostic update. Aust N Z J Surg (2000) 0.75
Suppression of in vitro lymphocyte reactivity to PHA by lysates from human placentae: lack of correlation with gravida number. Transplant Proc (1992) 0.75
Histocompatibility antigens in Omanis: Comparison with other Gulf populations and implications for disease association. Ann Saudi Med (2007) 0.75
Alveolar soft part sarcoma: ultrastructural and immunohistological studies with monoclonal antibodies. Br J Clin Pract (1984) 0.75
Identification and characterisation of two glycoproteins of molecular weights 60 and 180 kd from human multigravid placenta having strong in vitro immunosuppressive activity. Transplant Proc (1992) 0.75
Immunoglobulins, immunoglobulin G subclasses and complement in adult Omanis. Ann Saudi Med (1997) 0.75
Ethical issues -- a Middle East perspective. Transplant Proc (1989) 0.75
Identification of a novel 4 kDa immunoglobulin-A-binding peptide obtained by the limited proteolysis of jacalin. Biochim Biophys Acta (1993) 0.75
Pregnancy in renal transplantation recipients: outcome and complications in 44 pregnancies. Transplant Proc (1995) 0.75
Immunopathological changes in the spleen of BALB/c mice treated with either cyclosporine A or cyclosporine G. Transplant Proc (1989) 0.75
Omani experience with a heterogeneous group of kidney transplant recipients over a 10-year period. Transplant Proc (1993) 0.75
Non-traumatic intramural haematoma: an unusual cause of duodenal obstruction. Br J Surg (1984) 0.75
Cyclosporine A versus cyclosporine G: a comparative study of survival, hepatotoxicity, nephrotoxicity, and splenic atrophy in BALB/c mice. Transpl Int (1988) 0.75
Symptomatic response to ascorbic acid. Br J Urol (1996) 0.75
Herniation through an iatrogenic ilial bone defect. Br J Clin Pract (1984) 0.75
Living kidney donation for the mentally impaired. A case report. Transplant Proc (2003) 0.75
Impact of renal transplantation on liver disease of diverse etiology. Transplant Proc (1992) 0.75
Age and dose dependence of cyclosporine G nephrotoxicity in BALB/c mice. Transplant Proc (1987) 0.75
The new chimaera: the industrialization of organ transplantation. International Forum for Transplant Ethics. Transplantation (2001) 0.75
Factors responsible for elimination of potential kidney donors in a living-related donor kidney transplant program. Transplant Proc (1992) 0.75
Ethical aspects of living donor kidney transplantation and recipient adherence to treatment. Prog Transplant (2003) 0.75
Societal issues in organ transplantation. Ann Transplant (1998) 0.75
Neurilemoma of femoral nerve-a possible pitfall. Br J Clin Pract (1981) 0.75